Personal tools

Coexpression cluster:C180

From FANTOM5_SSTAR

Revision as of 16:23, 18 May 2012 by Autoedit (talk | contribs) (Created page with "{{Coexpression_clusters |full_id=C180_skeletal_heart_Hepatocyte_acute_occipital_hippocampus_middle |id=C180 }}")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Full id: C180_skeletal_heart_Hepatocyte_acute_occipital_hippocampus_middle



Phase1 CAGE Peaks

Hg19::chr11:114126059..114126109,+p@chr11:114126059..114126109
+
Hg19::chr1:160111262..160111295,+p@chr1:160111262..160111295
+
Hg19::chr1:160113171..160113182,+p@chr1:160113171..160113182
+
Hg19::chr1:569901..569922,+p1@ENST00000416718
Hg19::chr1:569934..569952,-p@chr1:569934..569952
-
Hg19::chr2:88124475..88124516,+p1@MT-ATP8
Hg19::chr3:25508993..25509011,+p@chr3:25508993..25509011
+
Hg19::chr4:8036848..8036871,-p@chr4:8036848..8036871
-
Hg19::chr5:134259184..134259218,-p@chr5:134259184..134259218
-
Hg19::chr5:134259896..134259899,+p2@MTND6P4
Hg19::chr5:134260273..134260314,-p@chr5:134260273..134260314
-
Hg19::chr5:134261636..134261669,-p1@MTND5P11
Hg19::chr5:134262765..134262773,-p@chr5:134262765..134262773
-
Hg19::chr5:134264011..134264014,-p1@MIR4461
Hg19::chr8:100508136..100508173,-p@chr8:100508136..100508173
-
Hg19::chrM:10053..10073,+p1@AB017116
Hg19::chrM:10173..10184,+p11@uc004cov.3
Hg19::chrM:10464..10480,+p1@uc004cov.3
Hg19::chrM:10568..10581,+p5@uc004cov.3
Hg19::chrM:10642..10656,+p8@uc004cov.3
Hg19::chrM:10671..10697,+p3@uc004cov.3
Hg19::chrM:10722..10734,+p7@uc004cov.3
Hg19::chrM:10741..10754,+p4@uc004cov.3
Hg19::chrM:10758..10771,+p6@uc004cov.3
Hg19::chrM:10850..10862,+p9@uc004cov.3
Hg19::chrM:10882..10893,+p12@uc004cov.3
Hg19::chrM:10902..10945,+p2@uc004cov.3
Hg19::chrM:11163..11176,+p1@AK129724
Hg19::chrM:11216..11233,+p2@AK129724
Hg19::chrM:11243..11254,+p3@Y17178
Hg19::chrM:11272..11283,+p2@Y17178
Hg19::chrM:11324..11335,+p4@Y17178
Hg19::chrM:11437..11449,+p1@Y17178
Hg19::chrM:11554..11580,-p@chrM:11554..11580
-
Hg19::chrM:11795..11807,+p1@uc004cow.1
Hg19::chrM:12331..12348,+p1@uc004cox.3
Hg19::chrM:12769..12780,+p2@uc004cox.3
Hg19::chrM:13632..13643,+p@chrM:13632..13643
+
Hg19::chrM:13938..13949,+p@chrM:13938..13949
+
Hg19::chrM:13966..13989,+p@chrM:13966..13989
+
Hg19::chrM:14077..14089,+p@chrM:14077..14089
+
Hg19::chrM:15039..15050,+p3@BC016999
Hg19::chrM:15149..15161,+p4@BC016999
Hg19::chrM:15168..15192,+p2@BC016999
Hg19::chrM:15239..15263,+p1@BC016999
Hg19::chrM:15280..15291,+p5@BC016999
Hg19::chrM:15293..15304,+p3@AF391805
Hg19::chrM:15306..15332,+p2@AF391805
Hg19::chrM:15419..15448,+p1@AF391805
Hg19::chrM:15517..15545,+p1@uc004coz.1
Hg19::chrM:15611..15622,+p3@uc004coz.1
Hg19::chrM:16098..16117,+p2@uc004coz.1
Hg19::chrM:16145..16159,+p4@uc004coz.1
Hg19::chrM:16183..16194,+p9@uc004coz.1
Hg19::chrM:16229..16242,+p10@uc004coz.1
Hg19::chrM:16274..16381,-p@chrM:16274..16381
-
Hg19::chrM:16481..16490,-p@chrM:16481..16490
-
Hg19::chrM:2028..2040,+p6@uc004cos.3
Hg19::chrM:3299..3324,+p2@TPT1
Hg19::chrM:3434..3445,+p1@AF216862
Hg19::chrM:3565..3576,+p1@AK123234
Hg19::chrM:3695..3706,+p2@AK123234
Hg19::chrM:4012..4049,+p1@M25300
Hg19::chrM:4716..4729,+p1@AK026903
Hg19::chrM:4817..4837,+p4@AF275801
Hg19::chrM:4876..4946,+p2@AF275801
Hg19::chrM:4960..4989,+p1@AF275801
Hg19::chrM:5028..5039,+p5@AF275801
Hg19::chrM:5113..5148,+p3@AF275801
Hg19::chrM:526..537,-p4@uc004coq.3
Hg19::chrM:5984..6024,+p7@uc011mfh.1
Hg19::chrM:6190..6248,+p2@uc011mfh.1
Hg19::chrM:6250..6272,+p4@uc011mfh.1
Hg19::chrM:6330..6392,+p1@uc011mfh.1
Hg19::chrM:6437..6448,+p3@AK026547
Hg19::chrM:6463..6517,+p1@AK026547
Hg19::chrM:6523..6548,+p2@AK026547
Hg19::chrM:6608..6637,+p4@AK026547
Hg19::chrM:6910..6936,+p1@BC018860
Hg19::chrM:7109..7147,+p4@uc004cou.3
Hg19::chrM:7213..7257,+p7@uc004cou.3
Hg19::chrM:7604..7655,+p1@uc004cou.3
Hg19::chrM:7678..7687,+p10@uc004cou.3
Hg19::chrM:7689..7700,+p5@uc004cou.3
Hg19::chrM:7772..7783,+p11@uc004cou.3
Hg19::chrM:7787..7811,+p3@uc004cou.3
Hg19::chrM:7840..7897,+p2@uc004cou.3
Hg19::chrM:7993..8026,+p6@uc004cou.3
Hg19::chrM:8423..8463,+p1@uc011mfi.1
Hg19::chrM:8512..8534,-p@chrM:8512..8534
-
Hg19::chrM:8630..8675,+p2@uc011mfi.1
Hg19::chrM:8717..8734,-p4@AF271776
Hg19::chrM:9226..9255,+p1@AL359334
p1@L08441
Hg19::chrM:9538..9549,+p2@BC023992
Hg19::chrX:125606790..125606809,+p1@MTND4P24


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=Coexpression_cluster:C180&oldid=1697820"